Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A rapid library screen for tailoring beta-peptide structure and function.

Joshua A Kritzer1, Nathan W Luedtke, Elizabeth A Harker

  • 1Department of Chemistry, Yale University, New Haven, Connecticut 06520, USA.

Journal of the American Chemical Society
|October 20, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dynamic Covalent Programming at DNA Base-Pairing Interfaces.

Journal of the American Chemical Society·2026
Same author

Minimal <i>N</i>-methylated and stapled peptide inhibitors of the autophagy protein GABARAP.

RSC chemical biology·2026
Same author

Minimal <i>N</i> -methylated and stapled peptide inhibitors of the autophagy protein GABARAP.

bioRxiv : the preprint server for biology·2026
Same author

Purification of post-transcriptionally modified tRNAs for enhanced cell-free translation systems.

Nucleic acids research·2026
Same author

Co-Translational Incorporation of <i>(R)</i>- and <i>(S)</i>-β<sup>2</sup>-Hydroxy Acids <i>In Vitro</i>: A Structural and Biochemical Study on the <i>E. coli</i> Ribosome.

Journal of the American Chemical Society·2026
Same author

Co-Translational Incorporation of (<i>R</i>)- and (<i>S</i>)-β<sup>2</sup>-Hydroxyacids <i>In Vivo</i>: Directed Evolution of Efficient Aminoacyl-tRNA Synthetases.

Journal of the American Chemical Society·2026

Researchers developed novel beta-peptide synthesis and screening methods to identify improved analogues of beta53-1. These new molecules show enhanced binding affinity and structural properties for the oncoprotein human double minute 2 (hDM2).

Area of Science:

  • Medicinal Chemistry
  • Peptide Chemistry
  • Structural Biology

Background:

  • A previously described beta-decapeptide (beta53-1) binds the oncoprotein human double minute 2 (hDM2) and inhibits its interaction with the p53 activation domain (p53AD).
  • Structural analysis revealed beta53-1 adopts a 14-helix with C-terminal unwinding, mimicking p53AD side-chain presentation for hDM2 recognition.
  • This structure-function insight suggested that modifying non-recognition faces could yield higher-affinity hDM2 binders.

Purpose of the Study:

  • To develop efficient beta-peptide synthesis and screening platforms for identifying novel hDM2 inhibitors.
  • To discover beta53-1 analogues with improved structural stability and enhanced binding affinity for hDM2.

Main Methods:

  • Development of one-bead-one-beta-peptide libraries using optimized synthesis protocols for direct on-bead screening.

Related Experiment Videos

  • Implementation of a versatile and scalable on-bead screening assay for identifying active compounds.
  • Utilization of a simple tandem mass spectrometry (MS/MS) method for rapid decoding of identified analogues.

    • Main Results:

    • Successful generation of high-quality beta-peptide libraries suitable for screening without prior purification.
    • Identification of beta53-1 analogues exhibiting superior structural and functional characteristics compared to the parent peptide.
    • Demonstration of improved affinity for hDM2 in the identified analogues.

    Conclusions:

    • The developed synthesis and screening methodology enables the discovery of potent beta-peptide therapeutics.
    • Novel beta53-1 analogues with enhanced hDM2 binding offer promising leads for drug development targeting hDM2-mediated pathways.
    • The study highlights the potential of structure-guided design and combinatorial library approaches in peptide drug discovery.